Literature DB >> 6084251

Development of sporozoite vaccines.

R S Nussenzweig, V Nussenzweig.   

Abstract

Protective immunity against malaria has been achieved in hosts ranging from birds to man by repeated inoculation of irradiated sporozoites. The main antigens involved in protective immunity to sporozoites are the circumsporozoite (CS) proteins, which are part of a family of proteins, covering the whole surface membrane of the parasite, and which have similar physico-chemical and antigenic properties. Monovalent fragments of monoclonal antibodies to CS proteins neutralize sporozoite infectivity. All monoclonal antibodies recognize a single immunodominant region within the various CS proteins, and this region contains repetitive epitopes. The recurrent immunodominant epitope of the CS protein of P. knowlesi has been identified, and shown to consist of 12 tandemly repeated subunits of 12 amino acids. The dimer of the dodecapeptide was coupled to protein carriers, emulsified in Freund's complete adjuvant, and injected into rodents and monkeys. All animals made anti-peptide antibodies, and most of the antisera reacted with P. knowlesi CS protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6084251     DOI: 10.1098/rstb.1984.0113

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  18 in total

1.  Are we there yet? The road to a malaria vaccine.

Authors:  N Regina Rabinovich
Journal:  West J Med       Date:  2002-03

2.  Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria.

Authors:  M Salcedo; L Barreto; M Rojas; R Moya; J Cote; M E Patarroyo
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

3.  The evolution of amino acid repeat arrays in Plasmodium and other organisms.

Authors:  Austin L Hughes
Journal:  J Mol Evol       Date:  2004-10       Impact factor: 2.395

Review 4.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

5.  Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites.

Authors:  J U Que; S J Cryz; R Ballou; E Fürer; M Gross; J Young; G F Wasserman; L A Loomis; J C Sadoff
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

6.  Sensitive and specific DNA probe for detection of Plasmodium falciparum.

Authors:  V Enea
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

7.  Major histocompatibility complex control of immunity elicited by genetically engineered Eimeria tenella (Apicomplexa) antigen in chickens.

Authors:  R A Clare; H D Danforth
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

8.  Low-complexity regions in Plasmodium falciparum: missing links in the evolution of an extreme genome.

Authors:  Martine M Zilversmit; Sarah K Volkman; Mark A DePristo; Dyann F Wirth; Philip Awadalla; Daniel L Hartl
Journal:  Mol Biol Evol       Date:  2010-04-28       Impact factor: 16.240

9.  Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.

Authors:  Thomas J Powell; Jie Tang; Mary E Derome; Robert A Mitchell; Andrea Jacobs; Yanhong Deng; Naveen Palath; Edwin Cardenas; James G Boyd; Elizabeth Nardin
Journal:  Vaccine       Date:  2013-02-26       Impact factor: 3.641

10.  Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection.

Authors:  Kaitian Peng; Yun Shan Goh; Anthony Siau; Jean-François Franetich; Wan Ni Chia; Alice Soh Meoy Ong; Benoit Malleret; Ying Ying Wu; Georges Snounou; Cornelus C Hermsen; John H Adams; Dominique Mazier; Peter R Preiser; Robert W Sauerwein; Anne-Charlotte Grüner; Laurent Rénia
Journal:  Cell Microbiol       Date:  2016-05-27       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.